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Summary
CHIP is a dimeric U box E3 ubiquitin ligase that binds
Hsp90 and/or Hsp70 via its TPR-domain, facilitating
ubiquitylation of chaperone bound client proteins.
We have determined the crystal structure of CHIP
bound to an Hsp90 C-terminal decapeptide. The struc-
ture explains how CHIP associates with either chaper-
one type and reveals an unusual asymmetric homo-
dimer in which the protomers adopt radically different
conformations. Additionally, we identified CHIP as
a functional partner of Ubc13-Uev1a in formation of
Lys63-linked polyubiquitin chains, extending CHIP’s
roles into ubiquitin regulation as well as targeted de-
struction. The structure of Ubc13-Uev1a bound to the
CHIP U box domain defines the basis for selective co-
operation of CHIP with specific ubiquitin-conjugating
enzymes. Remarkably, the asymmetric arrangement
of the TPR domains in the CHIP dimer occludes one
Ubc binding site, so that CHIP operates with half-of-
sites activity, providing an elegant means for coupling
a dimeric chaperone to a single ubiquitylation system.
Introduction
Protein-ubiquitin ligases (E3s) facilitate transfer of ubiq-
uitin from a covalent complex with a ubiquitin-conjugat-
ing enzyme (E2) to a target protein (or other ubiquitin
molecule), with formation of an isopeptide bond be-
tween the C-terminal carboxyl of ubiquitin and a lysine
side chain on the recipient. Target selectivity is provided
by the E3, whereas specificity for the recipient ubiquitin
lysine in formation of polyubiquitin chains may be deter-
mined by the E2 (Pickart and Eddins, 2004). The Lys48-
linked chains that mark proteins for degradation via the
proteasome (Hershko and Ciechanover, 1998) are gen-
erated by members of the Ubc4, Ubc5, and Ubc7 fami-
lies for example, whereas formation of Lys63-linked
chains, which act as a regulatory modification (Sun
and Chan, 2004), requires a heterodimer of Ubc13 and
either of the Ubc variants Uev1a or Mms2 (Hofmann
*Correspondence: laurence.pearl@icr.ac.ukand Pickart, 1999). Mechanistically, E3 enzymes fall
into one of two classes (Passmore and Barford, 2004).
HECT domain E3 ligases have an active mechanism in
which the ubiquitin C terminus is linked via a transient
thioester bond to a reactive cysteine in the HECT E3 pro-
tein. RING-finger and the structurally related U box E3 li-
gases are passive and act as scaffolds, maintaining the
target protein and E2-ubiquitin conjugate in proximity.
CHIP (C-terminal of Hsp70 interacting protein) is a di-
meric w35 kDa protein containing a C-terminal U box
domain and an N-terminal tetratricopeptide repeat
(TPR) domain that mediates its interaction with Hsp90
and Hsp70 chaperones. Originally characterized as a co-
chaperone regulator of the ATPase cycle of Hsp70 (Bal-
linger et al., 1999), in common with other U box proteins
(Hatakeyama et al., 2001), CHIP has subsequently been
shown to display E3 and E4 ubiquitin ligase activity
(Jiang et al., 2001; Murata et al., 2001). The combination
of chaperone binding and ubiquitin ligase activity sug-
gests a role for CHIP in client protein quality control, fa-
cilitating the switch from chaperone-mediated folding/
maturation to proteasome-mediated degradation via ly-
sine 48-linked polyubiquitylation (Cyr et al., 2002; Wie-
derkehr et al., 2002). However, CHIP can also autoubiq-
uitylate and facilitate polybiquitylation linked via lysines
other than lysine 48 (Alberti et al., 2002; Jiang et al., 2001;
Murata et al., 2001).
To gain further insight into the mechanism of CHIP-
mediated ubiquitylation and coupling to molecular
chaperones, we have determined the crystal structure
of CHIP in complex with a C-terminal decapeptide of
Hsp90. Additionally, we have identified CHIP as a binding
partner for the Lys63-specific ubiquitin-conjugating en-
zyme Ubc13-Uev1a, demonstrated that it collaborates
as an E3 ubiquitin ligase, and determined the structure
of a heterotrimeric complex between Ubc13-Uev1a
and the CHIP U box domain. These studies explain
CHIP’s ability to interact with Hsp90 or Hsp70, define the
basis for selective cooperation with specific ubiquitin-
conjugating enzymes, and reveal an elegant means for
coupling a dimeric chaperone to a single ubiquitylation
system, by formation of an asymmetric homodimer.
Results
Structure of CHIP
Mouse CHIP was cocrystallized with a C-terminal pep-
tide from human Hsp90a, and the structure solved by
molecular replacement using the structures of the
CHIP U box domain dimer (see below) and the PP5
TPR-domain (Das et al., 1998) as search models (see Ex-
perimental Procedures and Table 1). Although the crys-
tals only gave useful diffraction to 3.2 A˚, virtually all res-
idues are clearly defined, indicating that the limited
diffraction is due to the thinness (<20 mm) of the crystals
obtained and their high solvent content (73% v/v), rather
than significant disorder in the protein itself.
The N terminus of CHIP consists of a TPR-domain
formed by three pairs of antiparallel a helices (residues
26–131), with an elongated seventh helix whose N
Molecular Cell
526terminus packs against the third helical pair of the TPR
repeats (Figure 1A). Helix 7 has a different structure in
the two protomers of the CHIP dimer. In one, it is
a straight a helix from Asp134 to Arg183. In the other,
the polypeptide is broken into two separate and mutu-
ally perpendicular a helices, Asp134–Arg155 and
Glu161–Arg183, connected by residues Ile156–Ser160
in an extended conformation. In both protomers, the
chain reverses direction via a disordered loop
(Asn184–Asp190) into another a helix (helix 8), which
forms an antiparallel hairpin with the previous helix. As
with the N-terminal side, the C-terminal side of the heli-
cal hairpin has a different conformation in the two proto-
mers. In both cases, helix 8 is a continuous helix starting
at Gly192 but ending at Lys224 in the protomer with the
unbroken helix 7 and at Gln217 in the other. Beyond helix
8, in both cases, the polypeptide chain runs into a coil
forming the beginning of the C-terminal U box domain,
which has a similar structure in both protomers (Figure
1B). The U box domain consists of a pair of b hairpins
(232–240 and 244–254) running into a short a helix
(255–265), followed by a third hairpin (268–277) leading
to a C-terminal a helix (274–298). Beyond the end of
this helix, the two protomers again diverge; in the one
with the continuous helix 7, the chain from 299 to the
C terminus at 304 threads into a space between the
N-terminal end of helix 7 (144–149) and the extended
coil segment connecting the end of helix 8 to the begin-
ning of the U box domain (226–289). In the other proto-
mer, the N-terminal end of helix 7 is closely packed
Table 1. Crystallographic Statistics
CHIP[166-304]-
Ubc13-Uev1a CHIP-Hsp90C10
Data Collection ESRF ID14-eh3 ESRF ID14-eh3
Wavelength (A˚) 0.931 0.980
Space group C2 C2
Unit cell a = 180.31 A˚,
b = 69.99 A˚,
c = 204.48 A˚,
b = 106.9º
a = 76.04 A˚,
b = 204.41 A˚,
c = 144.71 A˚,
b = 90.75º
Resolution (A˚) 2.95 3.2
Observations (N) 146612 (21508) 109401 (14802)
Unique reflections (N) 49505 (7245) 31796 (4329)
Redundancy 3.0 (3.0) 3.4
Completeness (%) 96.1 (96.5) 98.0 (94.2)
Rmerge 0.065 (0.312) 0.109 (0.512)
I/sI 12.2 (3.6) 4.2 (1.2)
Z 4 2
Solvent content (v/v %) 57 73
Refinement
Rcryst 0.20 0.25
Rfree 0.28 0.29against the beginning of the U box domain with no gap
between them, so that the C terminus lies across the
contiguous surface formed by these segments.
Architecture of the Asymmetric CHIP Homodimer
CHIP dimerization involves two separate segments of
polypeptide: the U box domain and the distal segment
of the helical hairpins (Figure 2A). The U box domain
forms a parallel dimer, which buries >900 A˚2 of predom-
inantly hydrophobic molecular surface, and the isolated
U box domain shows some degree of dimerization in so-
lution. The core of the interface is provided by a symmet-
rical interaction between the amide side chains of
Asn284 from each protomer, buried between hydropho-
bic clusters (Tyr231, Leu285, Ala286, Met287, Val290,
and Phe294 and Ile246, Pro248, Gly250, and Ile282),
which pack with their equivalents in the other protomer.
(Figures 2B and 2C). All residues involved are strongly
conserved (Figure 1C). Apart from the extreme C termi-
nus, the two crystallographically independent U box do-
mains in the dimer are related byw2-fold symmetry and
are structurally very similar, with an rmsd on superposi-
tion of <0.5 A˚ over 67 Ca positions.
The core of the second dimer interface is provided by
a hydrophobic patch on the surface of the helical hair-
pin, involving Leu162, Tyr165, Leu166, Leu169, and
Ile170 from the N-terminal arm of the hairpin and
Tyr208, Met212, Leu215, Phe216, and Val219 from the
C-terminal arm, which pack with their equivalents in
the other protomer, forming a four-helix bundle. Corre-
sponding residues from the two hairpins make equiva-
lent contacts, so that the interacting regions are related
byw2-fold symmetry. However, the local 2-fold axis re-
lating the helical hairpins does not coincide with the lo-
cal 2-fold axis relating the U box domains but is tilted
w30º to it. The residues forming the second dimer inter-
face are also strongly conserved in CHIP sequences, al-
though the length of the hairpin varies between species.
Consistent with the crystal structure, residues 128–229
from human CHIP in isolation were found to be substan-
tially a-helical and dimeric in solution and their deletion
substantially disrupts overall CHIP dimerization and E3
ligase activity (Nikolay et al., 2004).
An important consequence of the dislocation of the lo-
cal dimer 2-fold axes, the breaking of the long helix in one
protomer, and the different locations of the two C termini
is that the two TPR domains have radically different po-
sitions with respect to their associated U box domain.
Thus, if the U boxes are considered to be orientated
East-West, the TPR domains are East-North (Figure
3A). In the elongated protomer, the TPR domain at the
N-terminal end of the hairpin does not contact the U
box at the C-terminal end, as the helices forming theFigure 1. Structure of CHIP Protomers
(A) Secondary structure cartoon of the elongated CHIP protomer, rainbow colored (blue/ red) from the N to C terminus, showing the tetratri-
copeptide-repeat domain (TPR) and the U box domain, linked via the long helical hairpin (HH). This and all other molecular graphics were pro-
duced by using MacPyMOL (http://www.pymol.org).
(B) As in (A) but for the compact protomer, with the U box domain in the same orientation. Rather than a continuous helix as in (A), the N-terminal
arm of the helical hairpin (HH’) is broken into two perpendicular segments.
(C) Alignment of exemplary CHIP sequences from mouse (Mm), human (Hs), chick (Gg), fish (Dr), fly (Dm), worm (Ce), and plant (At), with the sec-
ondary structures of the two chains in the mouse CHIP homodimer. Identical residues are in red, conserved residues are in yellow. The segments
comprising TPR, helical-hairpin, and U box domains are boxed in blue, green, and red, respectively. This figure was produced by using ESPript
2.2 (http://espript.ibcp.fr).
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528hairpin are splayed apart by the insertion of the C termi-
nus between them. In the other protomer, the TPR do-
main packs directly against the U box domain, with the
C terminus of helix 6 involved in polar interactions with
the C terminus of the first U box a helix (256–265),
whereas the N terminus of the broken helix 7 makes ex-
tensive polar and hydrophobic interactions along its full
length with the N-terminal b-hairpin turn of the U box
(232–240) and the preceding coil segment (224–232) (Fig-
ure 3B).
Hsp90 C-Terminal Binding to the CHIP TPR Domain
CHIP can bind the C terminus of either Hsp70 or Hsp90
(Ballinger et al., 1999; Connell et al., 2001) via its single
TPR domain, whereas Hop/Sti1, another TPR protein
able to bind both chaperones, utilizes different TPR do-
mains to provide selective and exclusive binding to one
or other chaperone (Scheufler et al., 2000). To under-
stand the promiscuity of CHIPs TPR-domain, we coc-
rystallized CHIP with a peptide (NH3+-DDTSRMEEVD-
COO2) corresponding to the C-terminal ten residues of
Hsp90a. CHIP bound this and a seven residue peptide
with KDs 2.8 and 2.2 mM, respectively, as determined
by isothermal titration calorimetry (ITC) (see Experimen-
tal Procedures), but bound significantly less tightly
(KD w90 mM) to a five residue peptide containing only
the MEEVD sequence. CHIP bound full-length human
Hsp90 with KD 4.9 mM, suggesting that most of the affin-
ity of CHIP for Hsp90 resides in the TPR-domain-peptide
interaction.
Difference Fourier maps showed clear density for
a bound peptide in the groove defined by the concave
surface of the TPR-domains. Although the resolution is
only 3.2 A˚, the peptide is present in both TPR domains
of the CHIP dimer, and in both copies of the dimer in
the asymmetric unit, so that 4-fold geometric restraints
could be applied, giving high confidence for the refined
conformation. The main chain and side chain carboxyls
of the C-terminal Asp731 of the Hsp90a peptide make
polar interactions with the side chains of Lys31, Asn35,
Asn66, and Lys96 in the CHIP TPR domain, similar to
the interactions made by Asp731 with Lys229, Asn233,
Asn264, and Lys301 in the section TPR-domain of Hop
(Scheufler et al., 2000). Similarly, the hydrophobic inter-
action of Hsp90 Val730 with the side chains of Phe38
and Leu69 in CHIP reflects its interaction with Tyr236
and Ala267 in Hop, whereas the side chain of Hsp90a
Glu729 has a polar interaction with Lys96 reminiscent
of a weaker interaction with Lys301 in Hop. Consistent
with the similar side chain interactions, this terminal
EVD Hsp90 tripeptide segment has a similar main chain
conformation in the two different TPR-domain com-
plexes (Figure 4A).
Upstream of Glu729, the CHIP bound peptide departs
substantially from the Hop bound conformation. Rather
than an extended conformation, the main chain at Hsp90
residues Met727 and Glu728 makes a helical turn, bring-
ing the side chain of Glu728 and the peptide nitrogen of
Met727 into hydrogen bonding contacts with the side
chains of CHIP Lys73 and Asp135, respectively. This
backbone ‘‘kink’’ points the side chain of Met727 in the
opposite direction to the Hop complex and buries it in
a hydrophobic pocket formed by the side chains of
Lys96, Phe99, Phe100, Phe132, and Ile136. This pocketis a distinctive feature of the CHIP TPR and is not present
in Hop. Upstream of Met727, the Hsp90 peptide chain is
no longer bound within the channel of the TPR-domain
but runs out across the loop connecting the end of helix
6 to the beginning of helix 7. The hydrogen bond to the
peptide nitrogen of Met727 stabilizes the twisting of its
side chain into the hydrophobic pocket, and its absence
probably explains the weaker binding of the minimal
MEEVD pentapeptide compared to longer sequences.
Residues upstream of Met727 make no specific con-
tacts with CHIP and are less well ordered.
The difference in bound peptide conformations ex-
plains how CHIP can bind either Hsp90 or Hsp70. The
extended conformation in the Hop bound structures
keeps chaperone side chains upstream of EEVD in con-
tact with the TPR domains, which provide specific and
exclusive interactions for one or the other sequence.
In CHIP, the hydrophobic pocket provides a binding
site that accommodates either the methionine of
Hsp90 (DDTSRMEEVD) or the isoleucine of Hsp70
(GSGPTIEEVD) and, in doing so, twists the peptide into
a conformation whereby upstream residues, which dif-
fer between the two chaperones, are hoisted clear of
the TPR-domain groove so that no further specific con-
tacts are required (Figure 4B).
Identification of CHIP as a Ubc13-Uev1a
Interacting Protein
The E2 ubiquitin-conjugating enzyme Ubc13-Uev1a di-
rects formation of Lys63 linkages (Hofmann and Pickart,
1999) and collaborates with TRAF RING-domain E3 li-
gases in formation of Lys63-linked polyubiquitin chains
downstream of signaling through tumor necrosis factor,
interleukin 1, and Toll-like receptors (Shi et al., 1999)
(Deng et al., 2000; Wang et al., 2001). To identify proteins
other than TRAFs that interact with Ubc13-Uev1a, we at-
tached GST-Ubc13-Uev1a complex to glutathione Se-
pharose and incubated the beads with 293 cell extracts
(see Experimental Procedures). After extensive wash-
ing, the Ubc13-Uev1a complex and associated proteins
were released and separated by SDS-PAGE. A protein
band of w38 kDa (Figure 5A, top) was trypsinized and
identified as human CHIP by mass spectrometry. This
identification was strengthened by immunoblotting us-
ing an anti-CHIP antibody. To determine whether the as-
sociation of CHIP with Ubc13-Uev1a was direct, we an-
alyzed the interactions of the purified proteins in vitro.
We confirmed that CHIP does indeed form a complex
with Ubc13-Uev1a, that CHIP binds to Ubc13 and not
to Uev1a, and that Ubc13 can bind Uev1a and CHIP si-
multaneously in a heterotrimeric complex (Figure 5B).
To determine whether native Ubc13 and CHIP interact
in vivo, we transfected 293 cells with GST-Uev1a and an-
alyzed precipitated proteins as above. Immunoblotting
clearly shows coprecipitation of Ubc13 and CHIP with
GST-Uev1a, confirming the existence of an endogenous
Ubc13-CHIP in vivo (Figure 5C).
CHIP-Ubc13-Uev1a Catalyzes Formation
of Lys63-Linked Polyubiquitin Chains In Vitro
As CHIP was known to be a ubiquitin E3 ligase, its inter-
action with Ubc13-Uev1a suggested that a Uev1a-
Ubc13-CHIP complex might catalyze formation of
Lys63-linked polyubiquitin chains. This idea was
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529Figure 2. Architecture of the CHIP Homodimer
(A) Secondary structure of the CHIP homodimer, with each protomer rainbow colored as in Figure 1. The Hsp90 C-terminal decapeptide bound to
each TPR domain is shown in magenta. Distinct dimer contacts occur between the two U box domains and between the distal ends of the two
helical hairpins, which form a four helix bundle.
(B) View of the CHIP U box dimer showing side chains of residues in one chain packed against the molecular surface of the other chain. The CHIP
U box dimerization interface is primarily formed by mutual packing of residues projecting from the C-terminal helix of each monomer, with ad-
ditional interactions from residues in the first and second hairpin loops.
(C) The amide head group of Asn284 forms a symmetrical hydrogen-bond interaction with its equivalent in the other monomer and lateral inter-
actions with Thr252 in the same monomer. The strength of this polar interaction will be significantly enhanced by its burial in the hydrophobic
core of the interface.
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mains
(A) The CHIP dimer viewed along the local
2-fold relating the two U box domains (red)
clearly show the dramatically different rela-
tive location of the two TPR domains (blue).
The TPR domain of the elongated protomer
makes no direct contact with its associated
U box, whereas in the other protomer, the
TPR and U box domains are packed together.
(B) Details of the interface between the TPR
and U box domains of the compact protomer,
consisting of polar interactions surrounding
a core hydrophic interaction of Phe238 pack-
ing between the side chains of Pro137,
Arg141, and Lys144.validated by carrying out ubiquitylation reactions in vitro
in which CHIP, Ubc13-Uev1a, and UBE1 catalyzed for-
mation of polyubiquitin chains (Figure 5D, top panels).
Protein staining or immunoblotting failed to detect any
ubiquitin-CHIP conjugates, indicating that the polyubiq-
uitin chains are not attached covalently to CHIP. In con-
trast, CHIP paired with the E2 UbcH5a formed polyubiq-
uitin chains anchored to CHIP, as indicated by a ladder
of ubiquitin-CHIP conjugates (Figure 5D, bottom pan-
els). To test whether the polyubiquitin chains formed
by CHIP-Ubc13-Uev1a are linked via Lys63, we used
ubiquitin mutants with either Lys48 or Lys63 mutated
to Arg (Figure 5E). As expected, CHIP-Ubc13-Uev1a
formed polyubiquitin chains with either wild-type
ubiquitin [wt] or ubiquitin[R48], but not with ubiqui-
tin[R63]. In contrast, the CHIP-UbcH5a complex formed
polyubiquitin chains with all three ubiquitin species,suggesting that it is not specific for either Lys48 or
Lys63 in vitro.
Structure of CHIP-Ubc13-Uev1a Complex
To understand the interaction of CHIP and Ubc13-Uev1a
at a structural level, the purified proteins were cocrystal-
lized. Full-length CHIP with Ubc13 or Ubc13-Uev1a
yielded crystals; however, none gave useful diffraction.
A series of N-terminal deletion mutants were con-
structed, with a construct consisting of residues 166–
304 (C terminus) producing diffracting crystals when
cocrystallized with Ubc13-Uev1a. The structure of the
mCHIP[U]-hUbc13-hUev1a (CUU) complex was deter-
mined by molecular replacement using the structure of
the human Ubc13-Mms2 complex (Moraes et al., 2001)
and refined at 2.9 A˚ resolution (see Experimental Proce-
dures).
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531Figure 4. CHIP TPR Peptide Binding
(A) Detailed view of Hsp90 C-terminal decapeptide bound to the CHIP TPR domain. Whereas the C-terminal EVD sequence lies in an extended
conformation along the TPR channel, the side-chain of Met727 binds in a hydrophobic pocket, twisting the upstream residues out of the TPR
channel and free of specific interactions.
(B) Comparison of chaperone C-terminal peptide conformations (magenta) bound to cochaperone TPR domains. CHIP - Hsp90 C10 (left), Hop
(TPR2A) - Hsp90 C5 (middle), and Hop (TPR 1) - Hsp70 C10 (right).The CUU complex consists of a homodimer of the
CHIP U box domain with a Ubc13-Uev1a heterodimer
bound on either side (Figures 6A and 6B). Although the
CHIP construct comprised residues 166–304, clear elec-
tron density is only visible for residues 225–304, which
encompass the U box domain. Silver-stained PAGE of
dissolved crystals (data not shown) suggests that resi-
dues 166–224 are present but disordered. The structureof Ubc13 in the CUU complex is essentially identical to
the structure in complex with Mms2 alone (Moraes
et al., 2001; VanDemark et al., 2001). In particular, a puta-
tive catalytic residue Ubc13 Asn79 remains hydrogen
bonded to the peptide backbone and is not moved by
CHIP binding as has been suggested (Wu et al., 2003).
Uev1a is similar in structure to Mms2 but with additional
N-terminal residues that are mostly disordered in the
Molecular Cell
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(A) Identification of CHIP as a Ubc13-Uev1a binding protein in 293 cells. GST-Ubc13 and Uev1a or GST were immobilized on glutathione Sephar-
ose beads and incubated with 293 cell extracts. The Ubc13-Uev1a complex was released from the beads by treatment with PreScission prote-
ase. After concentration, the eluted proteins were subjected to SDS PAGE and the gel either silver stained (top) or transferred to a nitrocellulose
membrane and immunoblotted with antibodies that recognize CHIP (bottom). The silver-stained band was excised and identified as CHIP by
mass spectrometry after digesting the protein with trypsin.
(B) Bacterially expressed CHIP binds to Ubc13, but not to Uev1a, in vitro. GST-Ubc13, GST-Uev1a, and GST-CHIP were expressed in bacteria
and purified. Where indicated, GST tags were removed by treatment with PreScission protease (see Experimental Procedures). The purified pro-
teins (each at 4 mM) were incubated for 1 hr at 4ºC with 25 ml glutathione Sepharose beads in 0.1 ml of lysis buffer. The beads were washed three
times with 1 ml of lysis buffer and once with 1 ml of 10 mM Tris-HCl (pH 8). The bound proteins were released by denaturation in SDS, subjected to
SDS-PAGE, and stained with Coomassie blue.
(C) 293 cells transfected with pEBG6P (GST) or pEBG6P-Uev1A (GST-Uev1A) were extracted with lysis buffer and proteins precipitated by ad-
dition of glutathione Sepharose beads. After 1 hr at 4ºC, the beads were washed four times with 1 ml lysis buffer and once with 1 ml 10 mM
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533CUU complex. The relative orientations of Ubc13 and
Uev1a and their interface are similar to those observed
between Ubc13 and Mms2.
Structural Determinants of CHIP Specificity
for E2 Enzymes
Each CHIP U box domain in the dimer interacts indepen-
dently with a Ubc13 molecule, which itself interacts with
a Uev1a molecule (Figures 6A and 6B). The CHIP-Ubc13
E3-E2 interface in the CUU complex is similar in overall
structure to that in the C-Cbl–UbcH7 E3-E2 complex
(Zheng et al., 2000), with equivalent elements in the
CHIP U box and c-Cbl RING domains interacting with
equivalent sites on the E2 surfaces (Figure 6C). The
core interface involves a hydrophobic ridge on Ubc13
(Met64, Pro97, and Ala98) inserting into a hydrophobic
groove on the U box surface, between the short a helix
(254–265) and the tips of two hairpin turns (234–239
and 269–274). A second hydrophobic interaction is pro-
vided by the side chain of Phe238 from CHIP packing
between the side chains of Arg7 and Lys10 from the
N-terminal a helix of Ubc13 and the head group of
Arg7. These interactions are supported by a network
of polar contacts, including hydrogen bonds from the
main-chain carbonyl oxygens of CHIP Ile236 and
Pro270, with the side chains of Ubc13 Arg7 and Ser96
(Figure 6D). Analysis of Ubc sequences suggests that
these interactions, along with the side chain of Ala98,
determine the spectrum of Ubc enzymes with which
CHIP can cooperate. In addition to the functional inter-
action with Ubc13-Uev1a shown here, CHIP also coop-
erates with Ubc4 and the UbcH5 E2 enzyme family, but
not with E2-25K (HIP-2), UbcH2, UbcH3, or UbcH7 (Ha-
takeyama et al., 2001; Jiang et al., 2001; Murata et al.,
2001). Ubc4 and UbcH5 enzymes have the Ser-Pro-Ala
motif equivalent to residues 96–98 of Ubc13 and present
a very similar E3 binding surface as Ubc13. UbcH7, by
contrast, replaces the serine with lysine, which could
not be accommodated in the close-packed interface
with CHIP. Similar incompatibility is presented by
UbcH2 and UbcH3, which replace the Ser-Pro-Ala motif
with Asn-Pro-Thr and Thr-Ala-Leu, respectively,
whereas the Ala-Ala-Ala of E2-25k could not make the
hydrogen bond with the carbonyl of CHIP Pro270. It
has been reported that UbcH6 or UbcH8 cannot cooper-
ate with CHIP, even though the Ser-Pro-Ala motif is con-
served in these enzymes (Jiang et al., 2001; Murata et al.,
2001). However, in our hands, CHIP polyubiquitin conju-
gates were formed readily in the presence of UbcH6
(M.W., unpublished data), consistent with the role pro-
posed for these residues.CHIP Asymmetry and Binding of Ubiquitin-
Conjugating Enzymes
It is immediately clear when the CHIP U box dimer from
the CUU complex is superimposed on the full CHIP
structure (Figures 2A and 6A) that the TPR domain inter-
acting with its attached U box domain overlaps the po-
sition of Ubc13 and would prevent binding of Ubc13-
Uev1a to that U box domain. Indeed several of the U
box residues involved in binding Ubc13 are buried in
the interface between the U box and its associated
TPR domain in the full structure. The other TPR domain
makes no interaction with its associated U box and
presents no obstacle to binding of Ubc13-Uev1a (Figure
7A). A necessary consequence of this structural obser-
vation is that the full CHIP dimer should only bind a single
Ubc13 molecule. To test this, we measured the binding
of Ubc13 to CHIP by ITC. In either orientation of the ex-
periment (i.e., CHIP added to Ubc13 or Ubc13 added to
CHIP), we consistently observed formation of a CHIP-
Ubc13 complex with a 2:1 stoichiometry. However,
with the truncated CHIP construct (166–304) that lacks
a TPR domain but retains the ability to dimerize, we ob-
served clear 1:1 binding, showing that both U boxes are
competent in E2 binding in the absence of the TPR do-
mains (Figures 7B, 7C, and 7D).
Discussion
The structure of CHIP provides a rare example of a
homodimeric protein in which the protomers adopt sig-
nificantly different conformations. In the few other de-
scribed examples, homodimer asymmetry is concomi-
tant with ligand binding, whereas in CHIP, it is an
inherent property. An important consequence of this
asymmetry, confirmed experimentally, is the blockade
of one of the two binding sites for Ubc enzymes pro-
vided by the U box domains in the CHIP dimer. Thus,
a CHIP dimer binds a single Ubc, displaying effective
‘‘half-of-sites’’ activity and resolving the conundrum of
how two U box E3 ligase domains might cooperate in
formation of a monotonic polyubiquitin chain. Although
the two TPR domains occupy different locations in the
dimer, they are both competent for Hsp90 C-terminal
peptide binding, so that CHIP and Hsp90 form a dimer-
dimer complex. The asymmetric dimer structure of
CHIP provides an elegant means for coupling a single
ubiquitin conjugation system to a dimeric chaperone
(Figures 7E and 7F).
Since CHIP was recognized as an E3-ubiquitin ligase
(Jiang et al., 2001), it has been implicated in polyubiqui-
tylation and proteasomal targeting of a range ofTris-HCl (pH 8). The bound proteins were released by denaturation in SDS, subjected to SDS-PAGE, and immunoblotted with antibodies against
CHIP and Ubc13 (upper two panels). The expression of CHIP and Ubc13 was analyzed by immunoblotting after SDS-PAGE by using 20 mg cell
lysate protein (bottom two panels). Coprecipitation of endogenous Ubc13 and CHIP occurs when GST-Uev1a is expressed, but not with GST only.
(D) Polyubiquitylation was carried out for 1 hr at 30ºC in an assay comprising 20 ml of 50 mM Tris-HCl (pH 7.5), His6-E1 (0.1 mM), 1 mM Ubc13/Uev1a
(top row) or 1 mM UbcH5a (bottom row), ubiquitin (100 mM), and CHIP was as indicated, 5 mM MgCl2, 2 mM ATP. The reaction was initiated with
ATP, stopped by addition of SDS, subjected to SDS PAGE, stained with Coomassie blue (center column), or transferred to nitrocellulose and im-
munoblotted by using anti-ubiquitin (left column) or anti-CHIP antibodies (right column). Maximal polyubiquitylation with CHIP-Ubc13-Uev1a oc-
curs at 1 mM CHIP, whereas polyubiquitylation with CHIP-UbcH5a continues to increase up to 10 mM CHIP.
(E) Polyubiquitin chains synthesized by CHIP-Ubc13-Uev1a are linked via Lys63, whereas those synthesized by CHIP-UbcH5a do not use Lys48 or
Lys63 exclusively. The reaction was performed as in (A) by using 1 mM of Ubc13-Uev1a or 5 mM UbcH5a, with ubiquitin[K48R] or ubiquitin[K63R]
used instead of wild-type ubiquitin as indicated. Reaction products were subjected to SDS PAGE and immunoblotted with anti-
ubiquitin antibodies.
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(A) Secondary structure cartoon of the homodimerized CHIP[U]-Ubc13-Uev1a heterotrimeric complex viewed down the local 2-fold axis. Uev1a
molecules are shown in pink, Ubc13 molecules in yellow, and the separate chains of the CHIP U box dimer in orange and blue.
(B) As in (A) but rotated 90º clockwise around the horizontal. One U box domain is outlined.
(C) The RING domain in the c-Cbl-UbcH7 complex (outlined) interacts with the same region of the E2 enzyme as the U box domain of CHIP, al-
though the detailed interactions are different and E2 specific.
(D) Detail of the core interaction between CHIP (blue carbons) and Ubc13 (yellow carbons). Close interactions of residues 96, 97, and 98 in Ubc13
against the surface of CHIP define the spectrum of Ubc E2 enzymes that CHIP can collaborate with.
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535Figure 7. Half-of-Sites Activity in CHIP-Mediated Ubiquitylation
(A) Model of a full CHIP-Ubc13-Uev1a complex constructed by superimposing the U box dimer from the CUU complex on to the U box dimer in
the full CHIP-peptide complex. The asymmetric disposition of the TPR domains blocks one of the Ubc binding sites on the U box domains; how-
ever, each TPR domain remains available to bind a C-terminal peptide from each protomer of an Hsp90 dimer.
(B) ITC curve showing heats evolved on adding aliquots of Ubc13 to CHIP. Least-squares fitting of the data indicate micromolar affinity for the
interaction, with a stoichiometry (N = 0.44) consistent with formation of a Ubc13-CHIP2 complex.
(C) As in (B) but for the inverse titration in which aliquots of CHIP were progressively added to Ubc13. Again, the stoichiometry (N = 1.8) is fully
consistent with formation of a Ubc13-CHIP2 complex.
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536proteins, including ErbB2 (Xu et al., 2002; Zhou et al.,
2003), nitric oxide synthase (Jiang et al., 2003; Peng
et al., 2004), microtubule-associated Tau protein (Hata-
keyama et al., 2004; Petrucelli et al., 2004; Shimura et al.,
2004), cystic-fibrosis transmembrane-conductance reg-
ulator (Meacham et al., 2001; Younger et al., 2004),
SMAD proteins (Li et al., 2004), and E2A transcription
factors (Huang et al., 2004), several of which are known
Hsp90 clients. In collaboration with the E4 UFD2,
C. elegans CHIP is also involved in ubiquitylation of an
Hsp90 cochaperone, the myosin binding UNC45 (Hoppe
et al., 2004). Here, we have shown that CHIP associates
with Ubc13 in vivo and is able to promote formation of
Lys63-linked polyubiquitin chains in collaboration with
Uev1a-Ubc13 in vitro. This suggests that CHIP is not
only a protein quality control factor, but it also provides
the means for coupling regulatory Lys63 polyubiq-
uitylation to the client proteins of molecular chaperones.
To understand the significance of this in vivo, targets of
CHIP-mediated Lys63 ubiquitylation need be identified.
Lys63-linked polyubiquitylation is involved in a range of
nondegradative processes, including receptor-medi-
ated endocytosis (Galan and Haguenauer-Tsapis,
1997), error-free DNA repair (Hoege et al., 2002), ribo-
some stability (Spence et al., 2000), and signaling via
the TNF/IL-1 Toll-like receptor system (Deng et al.,
2000), which leads to the Lys63-linked polyubiquitylation
of NEMO, a regulatory subunit of the IKK complex. CHIP
involvement in this pathway is a particularly tantalizing
possibility, as several components of this system have
involvement with Hsp90 (Bouwmeester et al., 2004;
Chen et al., 2002) and preliminary data (data not
shown) suggest that CHIP is present in some IKK/NFkB-
associated complexes. Nevertheless, considerably
more work will be required to elaborate this possibility.
As CHIP can cooperate with different E2 enzymes
templating different ubiquitylation topologies, with
very different potential biological outcomes, it is likely
that the choice of E2 will be regulated. Conceivably,
the chaperone involved and the identity and/or state of
the chaperone bound client protein, the presumed tar-
get of CHIP-directed ubiquitylation, might play a role in
determining the type of E2 system recruited, but this re-
mains to be shown. It is also unclear, even for the better
characterized degradative ubiquitylation function of
CHIP, what roles are played by Hsp90-CHIP and
Hsp70-CHIP complexes, both of which exist in cells.
With a denatured model protein, either type of chaper-
one-CHIP complex was able to promote target polyubiq-
uitylation independently of the other (Murata et al.,
2001). However, CHIP-dependent ubiquitylation of the
bone fide Hsp90 client ErbB2 suggests a far more com-
plex process in which enzymatically active CHIP is re-
cruited to Hsp90-ErbB2 as a prerequisite for ubiquityla-tion of the client and consequent transfer to an Hsp70-
CHIP complex (Xu et al., 2002), again showing the close
interdependence of the Hsp70 and Hsp90 chaperone
systems.
Experimental Procedures
DNA Constructs
Human Ubc13, Uev1a, and CHIP were amplified from IMAGE ESTs
(2822013, 6065716, and 3847168, respectively) and cloned into
pGEX6P-1 (Amersham) for bacterial expression. FLAG CHIP was
created in a similar manner with a 50 KOZAK sequence and 30
FLAG tag being added by PCR and cloned into pCMV5 for expres-
sion in mammalian cells. DNA expressing ubiquitin, ubiquitin[K48R],
and ubiquitin[K63R] were cloned into pGEX6P-1. cDNA encoding
UBE1 was amplified, cloned into pCR2.1, and subcloned into the
BamHI site of EBG2T. Mouse CHIP and various subconstructs
were amplified from pooled cDNA and cloned into pRSETA.
Protein Expression and Purification
His6-tagged ubiquitin-activating enzyme 1 (UBE1) was expressed in
Sf21 cells and purified on Ni-NTA agarose. Ubc13, Uev1a, hCHIP,
ubiquitin, ubiquitin[K48R], and ubiquitin[K63R] were expressed in
E. coli with N-terminal GST tags and purified on glutathione Sephar-
ose (Pharmacia). GST tags were removed and proteins released by
cleavage with PreScission Protease (Pharmacia). Proteins were dia-
lyzed against 50 mM Tris-HCl (pH 7.5), 270 mM sucrose, 150 mM
NaCl, 0.1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 0.2 mM PMSF,
and 1 mM benzamidine and stored at 280ºC.
For structural studies, nearly full-length (residues 25–304) and
DTPR (166–304) constructs of mouse CHIP were cloned by PCR
from mouse cDNA, inserted with an appended N-terminal His6-tag
and poliovirus 3C protease recognition sequence into pRSETA, ex-
pressed in E. coli BL21(DE3), and purified by metal affinity chroma-
tography on Talon resin and by ion exchange on S-Sepharose. Frac-
tions were treated with PreScission protease (20 U/mg protein,
Pharmacia) to remove the N-terminal His6 tag, reapplied to Talon
resin, and then applied to a Superdex 200 PG gel-filtration column
equilibrated in 20 mM Tris (pH 7.5), 300 mM NaCl, 1 mM EDTA,
and 5 mM DTT. GST-Ubc13 and GST-Uev1a fusion proteins were
purified by ion exchange on Q-Sepharose and immobilized on GST
beads. Ubc13 or Uev1a was then released by PreScission cleavage
and further purified on a Superdex 75 PG gel-filtration column.
Cell Culture, Transfection, and Cell Lysis
293 cells were cultured in 15 cm dishes in Dulbecco’s modified Ea-
gle’s medium with 10% (v/v) fetal calf serum (FCS) and extracted
with lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% [v/v]
2-mercaptoethanol, 1% [w/v] Triton X-100, and complete proteinase
inhibitor cocktail [Roche]). After centrifugation for 15 min at 18,0003
g, the supernatant (termed cell extract) was decanted. Cells were
transfected with polyethylenimine as described (Durocher et al.,
2002).
Identification of Proteins in 293 Cell Extracts
Cell extract (40 ml) was incubated for 3 hr at 4ºC with 0.5 ml packed
glutathione Sepharose beads (Amersham) and GST-Ubc13 (23
nmol) and Uev1a (23 nmol). As a control, glutathione Sepharose
was added to GST (23 nmol) and the same amount of 293 cell lysate.
Beads were washed with 50 ml lysis buffer containing 250 mM NaCl
and 25 ml of 50 mM Tris-HCl (pH 8), 100 mM NaCl, 1 mM EDTA, 1 mM
DTT, 0.2 mM PMSF, 1 mM benzamidine, and 0.2% (w/v) Triton(D) As in (A) but with Ubc13 added to an N-terminally truncated CHIP construct. The affinity remains micromolar, but the stoichiometry (N = 0.8)
shows that two Ubc13 molecules are able to bind to each CHIP dimer in the absence of the TPR domains.
(E) N-terminal His-tagged Hsp90 was incubated with CHIP and/or Ubc13, as indicated. Hsp90 was precipitated by addition of TALON resin in
300 ml of buffer containing 50 mM Tris (pH 7.5), 300 mM NaCl, 0.5 mM TECP, 5 mM Imidazole, 0.1% NP40, and 1 mg/ml BSA. Washed beads
with bound proteins were boiled in SDS buffer, separated by SDS-PAGE, and visualized by immunoblotting with antibodies to Hsp90 (top),
CHIP (middle), and Ubc13 (bottom). Ubc13 is clearly coprecipitated only when CHIP is present, confirming formation of a CHIP-bridged complex
as shown in (F).
(F) Schematic of CHIP-mediated ubiquitylation of an Hsp90 bound client protein. The client protein (magenta) bound to the Hsp90 dimer is poly-
ubiquitylated (red) by a ubiquitin-conjugating enzyme (yellow) bound to one of the U box domains of CHIP (blue). CHIP functions as a ‘‘Y’’ adap-
tor, coupling a single ubiquitylation system to a dimeric chaperone.
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537X-100, resuspended, incubated for 16 hr at 4ºC with 4 mg PreScission
protease, and centrifuged. Supernatants were concentrated and di-
alyzed against 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1 mM EGTA,
0.1% (v/v) mercaptoethanol, 1 mM benzamidine, 0.1 mM PMSF, and
50% (v/v) glycerol. Mass spectrometry was carried out by using an
Applied Biosystems (Foster City, CA, USA) 4700 Proteomics ana-
lyzer, and the data searched by using the Mascot program (Perkins
et al., 1999).
Crystallization, Data Collection, and Structure Determination
For the heterotrimeric complex, mCHIP(166–304), Ubc13, and Uev1a
were combined in a 1:1:1 molar ratio, incubated for 30 min, and con-
centrated to w10 mg/ml by ultrafiltration. Crystals were grown by
vapor diffusion at 20ºC against 20% (w/v) PEG2000 MME, 100 mM
Tris-HCl (pH 7.0). For the full CHIP structure, mCHIP was mixed
with human Hsp90a C-terminal peptide (NH3+-DDTSRMEEVD-
COO2) at a 1:3 molar ratio, respectively, incubated for 30 min at
4ºC, and concentrated tow10 mg/ml by ultrafiltration with a 5K Vi-
vaspin concentrator. Initial multiple crystals were grown by vapor
diffusion at 20ºC against 30% w/v PEG4000, 100 mM Tris (pH 7.5),
and 200 mM lithium sulfate. Subsequent streak seeding into solu-
tions of 16% w/v PEG4000, 100 mM Tris (pH 7.5), and 400 mM lithium
sulfate produced single plates. Crystals were harvested into reser-
voir solution with addition of glycerol (20% v/v) before flash cooling
to 100K. X-ray data were collected on beamline ID14-eh3 at the
ESRF, Grenoble, from single crystals, and processed by using
MOSFLM (Leslie, 1995) and the CCP4 package (CCP4, 1994). Both
types of crystals had space group C2, with four copies of the com-
plex in the asymmetric unit for the heterotrimeric CUU complex and
two copies of the dimer in the asymmetric unit of the full CHIP com-
plex. The structure of the heterotrimeric complex was solved by mo-
lecular replacement with Phaser (CCP4, 1994) using human Ubc13-
Mms2 (PDB code: 1JAT) as search model, and the resulting CHIP U
box structure was then used along with the TPR domain from PP5
(PDB code: 1A17) as search models to solve the full CHIP-peptide
complex structure. Both structures were built into difference Fourier
density by using O (Jones et al., 1991) and COOT (Emsley and Cow-
tan, 2004) and refined with CNS (Brunger et al., 1998) and REFMAC
(CCP4, 1994). Crystallographic statistics are given in Table 1.
Isothermal Titration Calorimetry
Heats were measured on a MSC system (Microcal), with proteins
in 40 mM Tris (pH 8.0), 1 mM EDTA, and 50 mM NaCl at 30ºC. For
CHIP interactions, 10 aliquots of 27 ml of 200 mM CHIP were injected
into 15 mM Hsp90 b or 300 mM PEP5 (NH3+-MEEVD-COO2), PEP7
(NH3+-SRMEEVD-COO2), or PEP10 (NH3+-DDTSRMEEVD-COO2)
were injected into 30 mM CHIP. For Ubc13 interactions, 10 aliquots
of 27 ml of 300 mM Ubc13 were injected into 30 mM CHIP or
CHIP[166–304] or 27 ml aliquots of 300 mM CHIP were injected into
30 mM Ubc13. Heats of dilution were determined in a separate exper-
iment and the corrected data fitted with three floating variables: stoi-
chiometry, binding constant, and change in enthalpy of interaction.
For the Hsp90-PEP5 experiment, the stoichiometry was fixed at 1.0.
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